Provided by Tiger Trade Technology Pte. Ltd.

Novo-Nordisk A/S

43.01
+1.303.10%
Volume:6.13M
Turnover:262.16M
Market Cap:192.02B
PE:10.74
High:43.10
Open:41.97
Low:41.97
Close:41.71
52wk High:64.16
52wk Low:35.12
Shares:4.47B
Float Shares:3.19B
Volume Ratio:1.55
T/O Rate:0.19%
Dividend:1.72
Dividend Rate:4.00%
EPS(TTM):4.00
EPS(LYR):3.62
ROE:59.82%
ROA:18.73%
PB:5.90
PE(LYR):11.88

Loading ...

Moderately bullish activity in Novo Nordisk with shares up 1.51%

TIPRANKS
·
Jul 02

Novo Nordisk A/S Stock Rises Wednesday, Outperforms Market

Dow Jones
·
Jul 02

European Equities Traded in the US as American Depositary Receipts Fall Sharply in Wednesday Trading

MT Newswires Live
·
Jul 01

Movement Alert|Novo Nordisk Rises 3.18% in Regular Trading, US Medicare Begins Covering GLP-1 Weight-Loss Drugs for First Time

Market Focus
·
Jul 01

The Latest Senior-citizen Special is Here: Cheap Weight-loss Drugs

Dow Jones
·
Jul 01

Novo Holdings CEO Says Commitment to Planetary Health Investing Remains Steadfast

Reuters
·
Jul 01

Medicare GLP-1 Bridge Program Will Pay for Novo, Lilly Drugs

Dow Jones
·
Jul 01

Millions of Americans Can Get Medicare to Cover Glp-1s for Weight Loss Starting This Week. Here's How Much it Costs.

Dow Jones
·
Jul 01

US Medicare to Cover Weight-Loss Drugs for the First Time from July, Boosting Novo Nordisk Shares

Deep News
·
Jun 30

Jefferies Sticks to Their Hold Rating for Novo Nordisk (0QIU)

TIPRANKS
·
Jun 30

Canada Approves Apotex's Bid to Sell Generic Version of Wegovy

Dow Jones
·
Jun 30

Novo Nordisk Accelerates Share Buybacks Under DKK 15 Billion Programme

TIPRANKS
·
Jun 30

Novo Nordisk A/S Stock Falls Monday, Underperforms Market

Dow Jones
·
Jun 30

FDA Set to Review Sandoz's Generic Glp-1s

Reuters
·
Jun 29

Analysts Offer Insights on Healthcare Companies: Novo Nordisk (NVO) and Sanofi (SNY)

TIPRANKS
·
Jun 29

Older Americans Will Soon Have Medicare Access to Glp-1s for Weight Loss for the First Time. Here's What They Need to Know.

Dow Jones
·
Jun 28

Novo Nordisk A/S Stock Rises Friday, Outperforms Market

Dow Jones
·
Jun 27

Novo Nordisk Tests Cagrilintide in Patients Who Cannot Tolerate GLP-1 Weight-Loss Drugs

TIPRANKS
·
Jun 26

Novo Nordisk A/S Stock Rises Wednesday, Outperforms Market

Dow Jones
·
Jun 25

Millions of Older Americans Will Soon Have Medicare Access to Glp-1s for Weight Loss. Here's What They Need to Know.

Dow Jones
·
Jun 24